This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Efficacy of cyclo 1% spray

Efficacy of cyclo 1% spray
Reviewed by Fiona Rowe

7 April 2021 | Fiona Rowe (Prof) | EYE - Paediatrics, EYE - Strabismus
Share This

The aim of this study was to evaluate the efficacy and tolerability of cyclopentolate 1% spray in patients aged three to six years. This was a cross section parallel group study of 61 children. Thirty-one received cyclo 1% drops and 30 received cyclo 1% spray. There were no differences in age and gender for groups, or for iris colour and race. Mean numerical rating scale to evaluate distress levels was 6.4 ±1.2 and 4 ±1.44 respectively which was significant for children <6 years. Pupil diameter was 6.2 and 5.9, and spherical equivalent change was 1.50 versus 1.30D respectively which was not significant. There were no adverse events. Five in the spray group did not have adequate cycloplegia and all had dark irides. The authors conclude that cyclo spray is effective in reducing stress with cyclo administration in young children. However, this was only partially effective in children with dark irides and therefore, drops are preferable for them.

Efficacy of a cycloplegic agent administered as a spray in the pediatric population.
Vagge A, Del Noce C, Pellegrini M, et al.
JOURNAL OF PEDIATRIC OPHTHALMOLOGY AND STRABISMUS
2020;57:301-4.
Share This
Fiona Rowe (Prof)
CONTRIBUTOR
Fiona Rowe (Prof)

Institute of Population Health, University of Liverpool, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency